Hyperuricemia is a risk factor for the progression to end-stage renal disease in minimal change disease
Su Hyun Song, Tae Ryom Oh, Hong Sang Choi, Chang Seong Kim, Dong Ryeol Ryu, Sung Gyun Kim, Sun-Hee Park, Seong Kwon Ma, Soo Wan Kim, Eun Hui Bae,
Kidney Res Clin Pract. 2021;40(3):411-418.   Published online 2021 Sep 9     DOI: https://doi.org/10.23876/j.krcp.20.220
Citations to this article as recorded by Crossref logo
Utility of muscle ultrasound in nutritional assessment of children with nephrotic syndrome
Mona Hamed Gehad, Yousif Mohamed Yousif, Maha Ibrahim Metwally, Amany Mohammed AbdAllah, Lamiaa Lotfy Elhawy, Amal S. El-Shal, Ghada Mohammed Abdellatif
Pediatric Nephrology.2023; 38(6): 1821.     CrossRef
Recent updates in therapeutic approach using tolvaptan for autosomal dominant polycystic kidney disease
Yaerim Kim, Seungyeup Han
The Korean Journal of Internal Medicine.2023; 38(3): 322.     CrossRef
In Vitro Diagnostic Examination and Prognosis Surveillance by Hierarchical Heterojunction-Assisted Metabolic Analysis
Fangying Shi, Jie Zhou, Yonglei Wu, Xufang Hu, Qionghong Xie, Chunhui Deng, Nianrong Sun
Analytical Chemistry.2022; 94(29): 10497.     CrossRef
Mendelian randomization reveals causal effects of kidney function on various biochemical parameters
Sehoon Park, Soojin Lee, Yaerim Kim, Semin Cho, Hyeok Huh, Kwangsoo Kim, Yong Chul Kim, Seung Seok Han, Hajeong Lee, Jung Pyo Lee, Kwon Wook Joo, Chun Soo Lim, Yon Su Kim, Dong Ki Kim
Communications Biology.2022;[Epub]     CrossRef